http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d74b11b118df8d1ad4dd3e9f79340569
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Saito |
| name | Yoshiro Saito |
| given-name | Yoshiro |
| organization-name | Division of Medicinal Safety Science National Institute of Health Sciences Kawasaki‐ku Kanagawa Japan Department of Oral and Maxillofacial Surgery, Division of Oral Oncology, Showa University, School of Dentistry, 2-1-1 Kitasenzoku, Ohta-Ku, Tokyo 145-8515, Japan; Showa University Head and Neck Oncology Center, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8555, Japan Laboratory of Metabolism and Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University Division of Medicinal Safety Science National Institute of Health Sciences Kawasaki City Kanagawa Japan Department of Biochemistry School of Dentistry Showa University Tokyo Japan; Department of Oral and Maxillofacial Surgery School of Dentistry Showa University Tokyo Japan Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences Tohoku University Sendai Japan Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan (Y.S.). Human Stress Signal Research Center, National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan Division of Medicinal Safety Science and Disease Metabolome Project, National Institute of Health Sciences From the Chemotherapy Division, National Cancer Center Research Institute; Hepatobiliary and Pancreatic Oncology Division and Clinical Laboratory Division, National Cancer Center Hospital; Project Team for Pharmacogenetics, National Institute of Health Sciences; BioBusiness Group, Mitsui Knowledge Industry, Tokyo; Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, Kashiwa; and Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine,... Japan MHLW, Tokyo, Japan Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (Y.S.). Division of Medicinal Safety Science, National Institute of Health Science Tokyo Japan Systems Life Sciences Laboratory Department of Medical Life Systems Faculty of Life and Medical Sciences Doshisha University Kyotanabe Kyoto Japan Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University, 1-3 Miyakodani, Tatara, Kyotanabe, Kyoto, 610-0394, Japan. ysaito@mail.doshisha.ac.jp. Division of Medicinal Safety Science, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan and The Japan Severe Adverse Reactions (JSAR) Research Group, Tokyo, Japan 5NIH Sciences, Kamiyoga, Setagaya-ku, Tokyo, Japan Division of Medicinal Safety Science; National Institute of Health Sciences; Kawasaki Japan Japan MHLW-NIHS, Kanagawa, Japan Health Technology Research Center (HTRC), National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31, Midorigaoka, Ikeda, Osaka 563-8577, Japan, Research Institute for Environmental Management Technology (EM-TECH), AIST, 16-1, Onogawa, Tsukuba, Ibaraki 305-8569, Research Institute of Instrumentation Frontier (RIIF), AIST, 1-1-1, Umezono, Tsukuba, Ibaraki 305-8565, Japan, Research Center for Chemical Risk Management (CRM), AIST, 16-1, Onogawa, Tsukuba, Ibaraki 305-8569, Japan,... National Institute of Health Sciences, Division of Medicinal Safety Science Division of Medical Safety Science National Institute of Health Sciences 3‐25‐26 Tonomachi, Kawasaki‐ku Kawasaki‐shi Kanagawa Japan Division of Medicinal Safety Science; National Institute of Health Sciences; Setagaya Tokyo 158-8501 Japan Division of Medicinal Safety Science National Institute of Health Sciences Japan Japan MHLW-NIHS, Tokyo, Japan Division of Medical Safety Science, National Institute of Health Sciences, Kawasaki 210-9501, Japan Department of Hygienic Chemistry, Graduate School of Pharmaceutical Sciences, Hokkaido University; Human Stress Signal Research Center, National Institute of Advanced Industrial Science and Technology, Japan Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University Division of Medicinal Safety Science, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan National Institute of Health Sciences Tokyo Japan Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan Biochemistry and Immunochemistry National Institute of Health Science Tokyo Japan Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan Division of Medical Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan Division of Medical Safety Science National Institute of Health Sciences Kawasaki Japan Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa 210-9501, Japan Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. Director, Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan Human Stress Signal Research Center National Institute of Advanced Industrial Science and Technology (AIST) 1‐8‐31 Midorigaoka, Ikeda Osaka 563‐8577 Japan National Institute of Health Sciences, Kanagawa, Japan National Institute of Health Sciences, Tokyo, Japan Division of Medicinal Safety Science, National Institute of Health Sciences Japan National Institute of Health Sciences, Kanagawa, 2109501, Japan Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan. Department of Biochemistry, School of Dentistry, Showa University, Shinagawa, Tokyo 142-8555, Japan; Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan Division of Medicinal Safety Science, National Institute of Health Sciences, Kamiyoga 1-18-1, Setagaya, Tokyo 158-8501, Japan Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan; Division of Medicinal Safety Science National Institute of Health Sciences Kawasaki Japan Department of Medical Life Systems Faculty of Life and Medical Sciences Doshisha University Kyotanabe Kyoto Japan Graduate School of Pharmaceutical Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Tohoku University; Division of Medicinal Safety Science, National Institute of Health Sciences Division of Medicinal Safety Science, National Institute of Health Sciences Division of Medicinal Safety Science, National Institute of Health Sciences, 1–18–1 Kamiyoga, Setagaya-ku, Tokyo 158–8501, Japan Division of Medicinal Safety Science, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan. yoshiro@nihs.go.jp Project Team for Pharmacogenetics, Division of Xenobiotic Metabolism and Disposition, Division of Biochemistry and Immunochemistry, Division of Pharmacology, Division of Drugs, Division of Environmental Chemistry, and Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo;Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo;Genetics Division, National Cancer Center Research Institute, Tokyo;Gastrointestinal Oncology Division and Medical Oncology Division, National Cancer Center Hospital, Tokyo;Safety Science Research Division, Mitsubishi Research Institute, Inc, Tokyo;Department of Cardiology, Department of Cardiovascular Dynamics Research Institute, and Department of Pharmacy, National Cardiovascular Center, Suita;Division of Oncology/Hematology and Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Kashiwa, Kimie, Japan Division of Biochemistry and Immunochemistry, National Institute of Health Sciences National Institute of Health Sciences, Tokyo Women's Medical University;National Cancer Center Hospital, National Cancer Center Research Institute, Tokyo, Japan;National Cancer Center Hospital East, Chiba, Japan National Institute of Health Sciences, Kawasaki, Kanagawa, Japan Project Team for Pharmacogenetics, National Institute of Health Sciences. Project Team for Pharmacogenetics; Division of Biochemistry and Immunochemistry Systems Life Sciences Laboratory, Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University Department of Medical Life Systems, Faculty of Medical and Life Sciences, Doshisha University, Kyotanabe, Kyoto, Japan National Institute of Health Sciences Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University; Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University Division of Functional Biochemistry and Genomics, National Institute of Health Sciences. Division of Medicinal Safety Science National Institute of Health Sciences Tokyo Japan From the Project Team for Pharmacogenetics; Divisions of Medicinal Safety Sciences, Pharmacognosy and Phytochemistry, Biochemistry and Immunochemistry, and Pharmacology, National Institute of Health Sciences; Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University; Genetics Division, Research Institute, National Cancer Center, Tokyo; and Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan National Institute of Advanced Industrial Science and Technology, Human Stress Signal Research Center, 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan Division of Medical Safety Science, National Institute of Health Sciences, Kanagawa, 210-9501, Japan Project Team for Pharmacogenetics, Division of Biochemistry and Immunochemistry, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan. yoshiro@nihs.go.jp Faculty of Medical and Life Sciences, Doshisha University, Kyotanabe, Kyoto, Japan Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki City, Kanagawa, Japan. yoshiro@nihs.go.jp. National Institute of Health Sciences Kawasaki Kanagawa Japan |
Incoming Links
Total number of triples: 455.